Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: Differential sensitivity to cysteinyl leukotriene receptor antagonists

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 3, 1998, Pages 453-461

  Panettieri Jr , Reynold A ^b   Tan, Elaine M L ^b   Ciocca, Vincenzo ^b   Luttmann, Mark A ^b   Leonard, Thomas B ^b   Hey, Douglas W P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBACHOL; CHROMONE DERIVATIVE; CYSTEINYL LEUKOTRIENE RECEPTOR 2; DICARBOXYLIC ACID; EPIDERMAL GROWTH FACTOR; LEUKOTRIENE D4; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEMBRANE PROTEIN; MESSENGER RNA; POBILUKAST; PRANLUKAST; SCLEROPROTEIN; TOLUENESULFONIC ACID DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; ZAFIRLUKAST;

ARTICLE; ASTHMA; CELL CULTURE; DNA REPLICATION; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; TRACHEA; VASCULAR SMOOTH MUSCLE;

ASTHMA; CARBACHOL; CELLS, CULTURED; CHROMONES; DICARBOXYLIC ACIDS; DNA REPLICATION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE D4; MEMBRANE PROTEINS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, LEUKOTRIENE; RNA, MESSENGER; TOSYL COMPOUNDS; TRACHEA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032161343     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.3.2999     Document Type: Article

References (41)

1. Drazen, J. M., and K. F. Austen. 1987. Leukotrienes and airway responses. Am. Rev. Respir. Dis. 136: 985-998.
2. Piacentini, G. L., and M. A. Kaliner. 1991. The potential role of leukotrienes in bronchial asthma. Am. Rev. Respir. Dis. 143(Suppl.): S96-S99.
3. Henderson, W. R. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121: 684-697.
4. Hay, D. W. P., T. J. Torphy, and B. J. Undem. 1995. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol. Sci. 516: 304-309.
5. 4 in allergen-induced increases in airway smooth muscle in the rat. Am. Rev. Respir. Dis. 148: 413-417.
6. 4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am. J. Physiol. 269: L1S1-L157.
7. Panettieri, R. A. 1996. Regulation of growth of airway smooth muscle by second messenger systems. In Airway Wall Remodelling in Asthma. A. G. Stewart, editor. CRC Press, Inc., Boca Raton, FL. 269-293.
8. Panettieri, R. A., Jr., I. P. Hall, C. S. Maki, and R. K. Murray. 1995. α-Thrombin increases cytosolic calcium and induces human airway smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 13: 205-216.
9. A receptor-mediated phenomenon. Br. J. Pharmacol. 118: 191-197.
10. Wilson, J. W., and X. Li. 1996. Inflammation and cytokines in airway remodelling. In Airway Wall Remodelling in Asthma. A. G. Stewart, editor. CRC Press, Inc., Boca Raton, FL. 65-110.
11. Maghji, S., J. R. Sandy, W. Harvey, B. Henderson, and N. Ali. 1992. Stimulation of hone collagen and non-collagenous protein synthesis by products of 5-and 12-lipoxygenase: determination by use of a simple quantitative assay. Bone Mineral 18: 119-132.
12. Obata, T., Y. Okada, M. Motoishi, N. Nakagawa, T. Terawaki, and H. Aishita. 1992. In vitro antagonism of ONO-1078, a newly developed antiasthma agent, against peptide leukotrienes in isolated guinea pig tissues. Jpn. J. Pharmacol. 60: 227-237.
13. Fujiwara, H., N. Kurihara, Ohta, K. Hirata, H. Matsushita, H. Kanazawa, and T. Takeda. 1993. Effect of a new leukotriene receptor antagonist, ONO-1078, on human bronchial smooth muscle in vitro. Prostaglandins Leukot. Essential Fatty Acids 48: 241-246.
14. Taki, F., R. Suzuki, K. Torii, S. Matsumoto, H. Taniguchi, and K. Takagi. 1994. Reduction of the severity of bronchial hyperresponsiveness by the novel leukotriene antagonist 4-oxo-8-[4-(4-phenyl-butoxy)benzoylamino]-2-(tetrazol-5-yl)-4H-1-benzopyran hemihydrate. Arzneim.-Forsch. 44: 330-333.
15. Barnes, N. C., B. De Jong, and T. Miyamoto. 1997. Worldwide clinical experience with the first marketed leukotriene receptor antagonist. Chest 111: 52S-60S.
16. Krell, R. D., D. Aharony, C. K. Buckner, R. A. Keith, E. J. Kusner, D. W. Snyder, P. R. Bernstein, V. G. Matassa, Y. K. Lee, F. J. Brown, B. Hesp, and R. E. Giles. 1990. The preclinical pharmacology of ICI 204,219: a peptide leukotriene antagonist. Am. Rev. Respir. Dis. 141: 978-987.
17. Taylor, I. K., K. M. O'Shaughnessy, R. W. Fuller, and C. T. Dollery. 1991. Effect of cysteinyl-leukotriene receptor ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 337: 690-694.
18. 4 receptor antagonist, in subjects with bronchial asthma. Am. J. Respir. Crit. Care Med. 150: 618-623.
19. Hay, D. W. P., R. M. Muccitelli, S. S. Tucker, L. M. Vickery-Clark, K. A. Wilson, J. G. Gleason, R. F. Hall, M. A. Wasserman, and T. J. Torphy. 1987. Pharmacological profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. J. Pharmacol. Exp. Ther. 243: 474-481.
20. Torphy, T. J., I. Faiferman, J. G. Gleason, R. F. Hall, M. A. Lewis, C. Broom, H. M. Helfrich, J. F. Newton, and D. W. P. Hay. 1991. The preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist. Ann. NY Acad. Sci. 629: 157-167.
21. Panettieri, R. A., R. K. Murray, L. R. DePalo, P. A. Yadvish, and M. I. Kotlikoff. 1989. A human smooth muscle cell line that retains physiological responsiveness. Am. J. Physiol. 256: C329-C335.
22. Li, X., and J. W. Wilson. 1996. Fibrogenic eytokines in airway remodelling. In Airway Wall Remodelling in Asthma. A. G. Stewart, editor. CRC Press, Inc., Boca Raton, FL. 111-138.
23. Chu, M.-L., J. C. Myers, M. P. Bernard, J.-F. Ding, and F. Ramirez. 1982 Cloning and characterization of five overlapping cDNAs-specific for the human pro-α1(I) collagen. Nucleic Acids Res. 10: 5925-5934.
24. Pihlajaniemi, T., K. Tryggvason, J. C. Myers, M. Kurkinen, R. Lebo, M.-C. Cheung, D. J. Prockop, and C. D. Boyd. 1985. cDNA clones coding for the pro-α1(IV) chain of human type IV procollagen reveal an unusual homology of amino acid sequences in two halves of the carboxyl-terminal domain. J. Biol. Chem. 260: 7681-7687.
25. Bernard, M. P., M. Kolbe, D. Weil, and M.-L. Chu. 1985. Human cellular fibronectin: comparison of the carboxyl-terminal portion with rat identifies primary structural domain separated by hypervariable regions. Biochemistry 24: 2698-2705.
26. Krusius, T., and E. Ruoslahti. 1986. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc. Natl. Acad. Sci. USA 83: 7683-7687.
27. Fisher, L. W., J. D. Termine, and M. F. Young. 1989. Deduced ptoein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 264: 4571-4576.
28. Krusius, T., K. R. Gehlsen, and E. Ruoslahti. 1987. A fibroblast chondroitin sulfate proteoglycan core protein contains lectin-like and growth factor-like sequences. J. Biol. Chem. 262: 13120-13125.
29. Fort, P., L. Marty, M. Piechaczyk, S. El Sabrouty, C. Dani, P. Jeanteur, and J. M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldegyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13: 1431-1442.
30. Chirgwin, J. M., A. E. Przybyla, R. J. McDonald, and W. J. Rutter. 1983. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
31. Oikarinen, H., A. I. Oikarinen, E. M. L. Tan, R. P. Abergel, C. A. Meeker, M.-L. Chu, D. J. Prockop, and J. Uitto. 1985. Modulation of procollagen gene expression by retinoids. J. Clin. Invest. 75: 1545-1553.
32. Thomas, P. S. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77: 5201-5205.
33. Maniatis, T., A. Jeffrey, and D. G. Kleid. 1975. Nucleotide sequence of the rightward operator of phage. Proc. Natl. Acad. Sci. USA 72: 1184-1188.
34. 4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. Am. J Physiol. 271 (Lung Cell. Mol. Physiol. 15): L1014-L1022.
35. 4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. Am. J Physiol. 271 (Lung Cell. Mol. Physiol. 15): L1014-L1022.
36. Labat, C., J. L. Ortiz, X. Norel, I. Gorenne, J. Verley, T. S. Abram, N. J. Cuthbert, S. R. Tudhope, P. Norman, P. Gardiner, and C. Brink. 1992. A second cysteinyl leukotriene receptor in human lung. J. Pharmacol. Exp. Ther. 263: 800-805.
37. Coleman, R. A., R. M. Eglen, R. L. Jones, S. Narumiya, T. Shimizu, W. L. Smith, S.-E. Dahlen, J. M. Drazen, P. J. Gardiner, W. T. Jackson, T. R. Jones, R. D. Krell, and S. Nicosia. 1995. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Adv. Prostaglandin Thromboxane Leukot. Res. 23: 283-285.
38. Metters, K. M. 1995. Leukotriene receptors. J. Lipid Mediat. Cell Signal. 12: 413-427.
39. Gorenne, I., X. Norel, and C. Brink. 1996. Cysteinyl leukotriene receptors in the human lung: what's new? Trends Pharmacol. Sci. 17: 342-345.
40. Hand, J. M., S. F. Schwalm, I. M. Englebach, M. A. Auen, J. H. Mauser, and A. F. Kreft. 1989. Pharmacological characterization using selected antagonists of the leukotriene receptors mediating contraction of guinea-pig trachea. Prostaglandins 37: 181-191.
41. Romaris, M., A. Heredia, A. Molist, and A. Bassols. 1991. Differential effect of transforming growth factor β on proteoglycan synthesis in human embryonic lung fibroblasts. Biochim. Biophys. Acta 1093: 229-233.